Muscle Strength via Actin Depolymerization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for increasing muscle strength, such as resistance exercise, are time-consuming and ineffective for individuals unable to exercise, including those with muscle wasting disorders or limited mobility, requiring a more efficient solution to enhance muscle force without physical activity.
Innovation Solution
The use of pharmacological agents like F-actin disrupting agents, microtubule disrupting agents, and intermediate filament disrupting agents to transiently depolymerize actin in muscle tissue, reducing mechanical stiffness and increasing muscle strength, with agents like SMIFH2 and ATM-3507 administered to achieve rapid muscle strength enhancement.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If resistance exercise is used to increase muscle strength, then muscle strength improves, but treatment time is substantial and requires physical activity capability
Solution Approach 1:
The patent replaces mechanical exercise with a pharmacological system. Specifically, it uses F-actin disrupting agents (chemical compounds) to depolymerize actin filaments in muscle tissue, thereby reducing internal resistance and increasing muscle strength without requiring physical exercise. This substitution of mechanical action with chemical action directly resolves the contradiction by achieving muscle strength improvement without the time investment and physical capability requirements of traditional exercise.
2Strength
If resistance exercise is used to increase muscle strength, then muscle strength improves, but it requires physical activity capability which infirm and elderly subjects lack
Solution Approach 1:
The patent substitutes mechanical exercise with pharmacological intervention using F-actin disrupting agents. These agents can be administered systemically (e.g., orally or intravenously) and work directly on the muscle tissue to reduce internal resistance and enhance strength. This approach is particularly beneficial for infirm, elderly, or bed-ridden patients who cannot perform resistance exercise, as it eliminates the need for physical activity capability while still achieving the desired muscle strength improvement.
3Strength
If F-actin disrupting agents are used to increase muscle strength, then muscle strength increases rapidly, but actin structure is altered
Solution Approach 1:
The patent employs periodic or transient administration of F-actin disrupting agents to achieve the desired muscle strength enhancement. By controlling the timing, dosage, and duration of agent exposure, the treatment temporarily depolymerizes actin to reduce internal resistance and increase strength, then allows actin to repolymerize and restore structural stability. This periodic action enables the system to achieve the beneficial effect (increased muscle strength) while minimizing the adverse effect (actin structure alteration) through controlled, transient exposure rather than continuous disruption.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach leads to a significant increase in muscle strength, with improvements starting within hours and potentially exceeding pre-treatment levels by 10% to 10-fold, offering a rapid and effective alternative to traditional exercise-based methods.
Implementation Method 1
The use of pharmacological agents like F-actin disrupting agents, microtubule disrupting agents, and intermediate filament disrupting agents to transiently depolymerize actin in muscle tissue, reducing mechanical stiffness and increasing muscle strength
Data Source
AI summary
Provided herein are methods and compositions for increasing muscle strength, and for treating muscle wasting disorders, muscle degenerative disease, or exercise-induced weakness, and cancer.